Biliary Drainage Preceding Possible Pancreaticoduodenectomy. Are Self-expandable Metallic Stents (SEMS) Superior to Plastic Stents?

Sponsor
Helsinki University Central Hospital (Other)
Overall Status
Withdrawn
CT.gov ID
NCT03350763
Collaborator
(none)
0
1
2
96.4
0

Study Details

Study Description

Brief Summary

This study looks in to the rate of biliary stent dysfunction for plastic and metallic stents in patients who need biliary drainage due to a tumor in pancreas before possible pancreaticoduodenectomy. Complications related to the biliary decompression, and possible post-surgical complications in all patients are also recorded.

This trial aims to confirm whether metallic biliary stents really are superior to plastic stents as some previous studies suggest. Specific patient groups are also evaluated individually to see, whether patients with ongoing cholangitis at the time of diagnosis or patients receiving neoadjuvant treatments have less stent dysfunction cases and complications with metallic stents than with plastic stents.

Condition or Disease Intervention/Treatment Phase
  • Device: Tannenbaum 10 Fr biliary stent
  • Device: Self-expandable metallic biliary stent
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
0 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Biliary Drainage Preceding Possible Pancreaticoduodenectomy. Are Self-expandable Metallic Stents (SEMS) Superior to Plastic Stents?
Actual Study Start Date :
Nov 18, 2017
Anticipated Primary Completion Date :
Dec 1, 2025
Anticipated Study Completion Date :
Dec 1, 2025

Arms and Interventions

Arm Intervention/Treatment
Experimental: Plastic biliary stent

A plastic (ie Tannenbaum 10 Fr) biliary stent is used to achieve biliary decompression

Device: Tannenbaum 10 Fr biliary stent
Tannenbaum 10 Fr biliary stent

Experimental: Self-expandable metallic biliary stent

A self-expandable metallic biliary stent is used to achieve biliary decompression

Device: Self-expandable metallic biliary stent
ie WallFlex biliary RX

Outcome Measures

Primary Outcome Measures

  1. Stent failure rate, and need for re-procedure before pancreaticoduodenectomy. [Evaluation at the day of pancreatic surgery]

Secondary Outcome Measures

  1. Other complications related to preoperative biliary decompression, and post-surgical complications [Complication emerged within 120 days from pancreaticoduodenectomy]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Resectable tumor of the head of the pancreas

  • Elevated serum bilirubin levels

  • Radiologically visible dilatation of the biliary system

Exclusion Criteria:
  • Distant metastasis

  • Inoperable tumor or other reason, why the patient is unfit for surgery

Contacts and Locations

Locations

Site City State Country Postal Code
1 Helsinki University Hospital Helsinki Uusimaa Finland 00029

Sponsors and Collaborators

  • Helsinki University Central Hospital

Investigators

  • Principal Investigator: Leena Kylänpää, MD, PhD, Helsinki University Central Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Leena Kylanpaa, Head of department, Helsinki University Central Hospital
ClinicalTrials.gov Identifier:
NCT03350763
Other Study ID Numbers:
  • HUS/2470/2017
First Posted:
Nov 22, 2017
Last Update Posted:
May 19, 2021
Last Verified:
May 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Leena Kylanpaa, Head of department, Helsinki University Central Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 19, 2021